US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
JPS58403B2
(ja)
|
1975-07-24 |
1983-01-06 |
武田薬品工業株式会社 |
L− アスコルビンサンセイザイノ セイゾウホウ
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
US5135757A
(en)
|
1988-09-19 |
1992-08-04 |
Edward Mendell Co., Inc. |
Compressible sustained release solid dosage forms
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
FR2704146B1
(fr)
|
1993-04-19 |
1995-07-13 |
Cripdom |
Microcapsules d'acide acétylsalicylique à libération contrôlée.
|
US5773025A
(en)
|
1993-09-09 |
1998-06-30 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems--amorphous drugs
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
FR2725623A1
(fr)
|
1994-10-18 |
1996-04-19 |
Flamel Tech Sa |
Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
|
NZ525021A
(en)
|
1997-04-15 |
2004-05-28 |
Csir |
Pharmaceutical compositions having appetite suppressant activity
|
US5891919A
(en)
|
1997-09-19 |
1999-04-06 |
Burlington Bio-Medical & Scientific Corp. |
Denatonium capsaicinate and methods of producing the same
|
US6180365B1
(en)
|
1998-11-06 |
2001-01-30 |
Smithkline Beecham Corporation |
Polynucleotide encoding a Mouse 7-transmembrane GPR43 receptor
|
ITMI991316A1
(it)
|
1999-06-14 |
2000-12-14 |
Cip Ninety Two 92 S A |
Composizioni farmaceutiche orali a rilascio modificato di mesalazina
|
IL132313A0
(en)
|
1999-10-11 |
2001-03-19 |
Yeda Res & Dev |
Leptin assay
|
EP1255779A2
(en)
|
2000-02-18 |
2002-11-13 |
Glaxo Group Limited |
Identification of modulators of gpr41 or gpr42 activity
|
US20110217394A1
(en)
|
2000-12-05 |
2011-09-08 |
Brett Justin West |
Iridoid Based Formulations
|
US7998947B2
(en)
|
2001-03-28 |
2011-08-16 |
University Of South Florida |
Materials and methods for treatment of cancer and identification of anti-cancer compounds
|
US8030008B2
(en)
|
2001-04-05 |
2011-10-04 |
Senomyx, Inc. |
Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators
|
DK1463759T3
(da)
|
2002-01-07 |
2013-08-12 |
Euroscreen Sa |
Ligand for den G-proteinkoblede receptor GPR43 og anvendelser deraf
|
US20030171407A1
(en)
*
|
2002-03-07 |
2003-09-11 |
Upsher-Smith Laboratories, Inc. |
Composition for reducing blood glucose and cholesterol
|
US20060019346A1
(en)
|
2002-07-29 |
2006-01-26 |
Senomyx, Inc. |
Identification of a novel bitter taste receptor T2R76 that specifically responds to brucine and prop bitter ligands
|
CA2494281A1
(en)
*
|
2002-08-02 |
2004-02-12 |
Penwest Pharmaceuticals Company |
Sustained release formulations of metformin
|
WO2004033431A2
(en)
|
2002-10-04 |
2004-04-22 |
Arena Pharmaceuticals, Inc. |
Hydroxypyrazoles for use against metabolic-related disorders
|
US20060167270A1
(en)
|
2002-10-10 |
2006-07-27 |
Arena Pharmaceuticals Inc. |
5-substituted 2h-pyrazone-3-carbixylic acid derivatives as antilipolytic agents for the treatment of metabolic-related disorders such as dyslipidemia
|
AU2003273994A1
(en)
|
2002-10-25 |
2004-05-13 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43)
|
WO2004038421A2
(en)
|
2002-10-25 |
2004-05-06 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41)
|
AU2003277576A1
(en)
|
2002-11-08 |
2004-06-07 |
Takeda Pharmaceutical Company Limited |
Receptor function controlling agent
|
CN1413582A
(zh)
*
|
2002-11-29 |
2003-04-30 |
贵州圣济堂制药有限公司 |
盐酸二甲双胍肠溶片及其制备方法
|
US7919236B2
(en)
|
2002-12-18 |
2011-04-05 |
Givaudan Sa |
G-proteins
|
EP1597588A1
(en)
|
2003-02-17 |
2005-11-23 |
Bayer HealthCare AG |
Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 40 (gpr40)
|
DE10308504A1
(de)
|
2003-02-26 |
2004-09-09 |
Basf Ag |
Enzymatische Herstellung von (Meth)acrylsäureestern
|
CA2527691C
(en)
|
2003-05-30 |
2013-01-22 |
Takeda Pharmaceutical Company Limited |
Condensed ring compound
|
AU2004260636A1
(en)
|
2003-06-13 |
2005-02-10 |
Arena Pharmaceuticals, Inc. |
5-substituted 2H-pyrazole-3-carboxylic acid derivatives as agonists for the nicotinic acid receptor RUP25 for the treatment of dyslipidemia and related diseases
|
CA2532332C
(en)
|
2003-07-17 |
2007-10-02 |
Sante International, Inc. |
Dietary supplement for promoting control of blood-sugar levels and associated pathology in type 2 diabetics
|
WO2005023766A1
(en)
*
|
2003-09-11 |
2005-03-17 |
Biocon Limited |
Salt of atorvastatin with metformin
|
WO2005028488A1
(en)
|
2003-09-12 |
2005-03-31 |
Quatrx Pharmaceuticals Co. |
Heteroaryl phosphinyl and thiophosphinyl compounds for regulation of glucose, triglycerides, and ldl/hdl levels
|
PE20050483A1
(es)
|
2003-10-31 |
2005-08-25 |
Arena Pharm Inc |
Derivados de tetrazol de formula (i), sus composiciones farmaceuticas y procesos para producir composiciones farmaceuticas
|
WO2005051890A1
(en)
|
2003-11-19 |
2005-06-09 |
Smithkline Beecham Corporation |
Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40
|
AU2004293415A1
(en)
|
2003-11-21 |
2005-06-09 |
Arena Pharmaceuticals, Inc. |
4-oxo-4,5-dihydro-furan-2-carboxylic and acid derivatives and methods of treatment of metabolic-related disorders thereof
|
US7456218B2
(en)
|
2003-12-25 |
2008-11-25 |
Takeda Pharmaceutical Company Limited |
3-(4-benzyloxyphenyl) propanoic acid derivatives
|
EP1698624B1
(en)
|
2003-12-26 |
2012-06-27 |
Takeda Pharmaceutical Company Limited |
Phenylpropanoic acid derivatives
|
EP1726580A4
(en)
|
2004-03-15 |
2008-02-13 |
Takeda Pharmaceutical |
AMINOPHNYLPROPANO ACID DERIVATIVE
|
JP4859665B2
(ja)
|
2004-03-30 |
2012-01-25 |
武田薬品工業株式会社 |
アルコキシフェニルプロパン酸誘導体
|
WO2005102311A1
(en)
|
2004-04-20 |
2005-11-03 |
Deutsches Institut für Ernährungsforschung |
Agonists of a bitter taste receptor and uses thereof
|
JP2007284350A
(ja)
|
2004-07-27 |
2007-11-01 |
Takeda Chem Ind Ltd |
糖尿病治療剤
|
US20060024335A1
(en)
|
2004-07-29 |
2006-02-02 |
Roger Stier E |
Oral compositions which mask the bitter taste of a bitter-tasting agent
|
US9017949B2
(en)
|
2004-09-22 |
2015-04-28 |
Arena Pharmacueticals, Inc. |
Method of screening for compounds useful in the treatment of insulin resistance, impaired glucose tolerance or diabetes
|
JPWO2006038738A1
(ja)
|
2004-10-08 |
2008-05-15 |
武田薬品工業株式会社 |
受容体機能調節剤
|
AU2005305083B2
(en)
|
2004-11-03 |
2012-02-02 |
Arena Pharmaceuticals, Inc. |
GPR41 and modulators thereof for the treatment of insulin-related disorders
|
US7829299B2
(en)
|
2004-11-18 |
2010-11-09 |
Deutsches Institut fur Ernahrungforschung Potsdam-Rehbrucke Stiftung des Offentlichen Rechts |
Agonists of bitter taste receptors and uses thereof
|
PE20060949A1
(es)
|
2004-12-23 |
2006-10-11 |
Arena Pharm Inc |
Derivados fusionados de pirazol como agonistas del receptor de niacina
|
DOP2006000008A
(es)
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
|
WO2006083612A1
(en)
|
2005-01-28 |
2006-08-10 |
Merck & Co., Inc. |
Antidiabetic bicyclic compounds
|
WO2006083781A1
(en)
|
2005-01-31 |
2006-08-10 |
Merck & Co., Inc. |
Antidiabetic bicyclic compounds
|
US20060222709A1
(en)
*
|
2005-03-18 |
2006-10-05 |
Agi Therapeutics Research Ltd. |
Metformin methods and formulations for treating chronic constipation
|
WO2006102653A2
(en)
|
2005-03-24 |
2006-09-28 |
Irm Llc |
Methods and compositions for treating insulin resistance and obesity-induced diseases
|
BRPI0610034A2
(pt)
|
2005-04-28 |
2011-10-18 |
Ajinomoto Kk |
composto, agente de icremento do transporte de açúcar, agente hipoglicêmico, agente para prevenção e/ou tratamento de uma doença, medicamento, composição farmacêutica , uso do composto, e, método de preparação para o composto
|
EP1899304A1
(en)
|
2005-05-23 |
2008-03-19 |
Arena Pharmaceuticals, Inc. |
5-amino-1h-pyrazole-3-carboxylic acid derivatives as agonists for the g-protein coupled receptor (gpcr) rup38 for the treatment of metabolic-related disorders thereof
|
US20060269617A1
(en)
|
2005-05-26 |
2006-11-30 |
Suracell, Inc. |
Supplement compositions and method of use for enhancement of insulin sensitivity
|
US7939276B2
(en)
|
2005-06-22 |
2011-05-10 |
Senomyx, Inc. |
Assays which screen for compounds that modulate bitter taste of chlorogenic lactone compounds
|
EP1907422A1
(en)
|
2005-07-28 |
2008-04-09 |
Nestec S.A. |
Fat taste receptors and their methods of use
|
JP5084503B2
(ja)
|
2005-07-29 |
2012-11-28 |
武田薬品工業株式会社 |
シクロプロパンカルボン酸化合物
|
WO2007021744A1
(en)
|
2005-08-10 |
2007-02-22 |
Arena Pharmaceuticals, Inc. |
Methods for determining probability of an adverse or favorable reaction to a niacin receptor agonist
|
EP1932920A4
(en)
|
2005-09-02 |
2009-04-08 |
Eisai R&D Man Co Ltd |
METHOD FOR DETECTING EFFECTIVE SUBSTANCE AGAINST DISEASE USING GPR120 AND PHOSPHOLIPASE
|
WO2007049050A2
(en)
|
2005-10-27 |
2007-05-03 |
Heptahelix Ab |
Modulators of gpr40 for the treatment of diabetes
|
US20070104805A1
(en)
|
2005-11-01 |
2007-05-10 |
Udell Ronald G |
Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives
|
JP2007215162A
(ja)
|
2006-01-11 |
2007-08-23 |
Canon Inc |
情報処理装置及びその制御方法、プログラム、記憶媒体
|
US20070207227A1
(en)
|
2006-02-23 |
2007-09-06 |
Conopco, Inc., D/B/A Unilever, A Corporation Of New York |
Appetite suppressant compositions
|
WO2007116229A1
(en)
|
2006-04-06 |
2007-10-18 |
Prosidion Limited |
Heterocyclic gpcr agonists
|
WO2007116404A2
(en)
|
2006-04-10 |
2007-10-18 |
Bar-Ilan University |
Cucurbitacin glucosides and use thereof in treating cancer
|
DK1971862T3
(da)
|
2006-04-11 |
2011-02-14 |
Arena Pharm Inc |
Fremgangsmåder til anvendelse af GPR119-receptor til identificering af forbindelser anvendelige til øgning af knoglemasse hos en person
|
GB0607196D0
(en)
|
2006-04-11 |
2006-05-17 |
Prosidion Ltd |
G-protein coupled receptor agonists
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
TW200815377A
(en)
|
2006-04-24 |
2008-04-01 |
Astellas Pharma Inc |
Oxadiazolidinedione compound
|
AU2007254325B2
(en)
|
2006-05-15 |
2012-05-10 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
WO2007134613A1
(en)
|
2006-05-24 |
2007-11-29 |
Rheoscience A/S |
Modulation of gpr120 activity in adipocytes/fat tissue
|
EP2431367A3
(en)
|
2006-06-27 |
2012-07-04 |
Takeda Pharmaceutical Company Limited |
Fused cyclic compounds as GPR40 receptor modulators
|
CA2551706A1
(en)
|
2006-06-27 |
2007-12-27 |
Innovative Life Sciences Corporation |
Herbal product comprising cinnamon and bitter melon
|
CN100596277C
(zh)
|
2006-07-10 |
2010-03-31 |
博仲盛景医药技术(北京)有限公司 |
一种促进肠胃蠕动的药物组合物
|
EP2043744A2
(en)
|
2006-07-13 |
2009-04-08 |
SmithKline Beecham Corporation |
Chemical compounds
|
EP2051723A1
(en)
|
2006-08-17 |
2009-04-29 |
Unilever N.V. |
Processes for production of hoodia plant extracts containing steroidal glycosides
|
AP2009004773A0
(en)
|
2006-08-24 |
2009-02-28 |
Unilever Plc |
Process for preparing a composition comprising steroidal glycosides
|
CA2660699A1
(en)
|
2006-08-30 |
2008-03-06 |
Biovitrum Ab (Publ) |
Pyridine compounds for treating gpr119 related disorders
|
WO2008030429A2
(en)
|
2006-09-05 |
2008-03-13 |
Senomyx, Inc. |
Novel haplotype of human t2r receptor ht2r50 and its use in assays for identifying human bitter taste modulators
|
EP2064193A1
(en)
|
2006-09-07 |
2009-06-03 |
Amgen, Inc |
Heterocyclic gpr40 modulators
|
WO2008063321A2
(en)
|
2006-10-13 |
2008-05-29 |
Janssen Pharmaceutica N.V. |
Gpr81-ligand complexes and their preparation and use
|
WO2008054675A2
(en)
|
2006-10-31 |
2008-05-08 |
Merck & Co., Inc. |
Antidiabetic bicyclic compounds
|
WO2008054674A2
(en)
|
2006-10-31 |
2008-05-08 |
Merck & Co., Inc. |
Antidiabetic bicyclic compounds
|
BRMU8602999U
(pt)
*
|
2006-11-16 |
2008-07-08 |
Walter Junior Santos |
medicamento "rosuvastatina + metformina" em forma combinada para doenças cardiovasculares
|
WO2008058355A2
(en)
*
|
2006-11-16 |
2008-05-22 |
Walter Santos Junior |
Descriptive report of patent of invention of the medicament 'atorvastatin + metformin' in combined form for cardiovascular diseases
|
CN101190179B
(zh)
*
|
2006-11-20 |
2010-05-12 |
北京利龄恒泰药业有限公司 |
一种治疗糖尿病的肠溶药物组合物及其制备方法
|
AU2007326395B2
(en)
|
2006-12-01 |
2012-10-11 |
Msd K.K. |
Novel phenyl-isoxazol-3-ol derivative
|
TW200838526A
(en)
|
2006-12-01 |
2008-10-01 |
Astellas Pharma Inc |
Carboxylic acid derivatives
|
CN105152983A
(zh)
*
|
2007-01-29 |
2015-12-16 |
韩诺生物制药株式会社 |
N,n-二甲基亚氨基二碳亚氨酸二酰胺乙酸盐、其制备方法和包含其的药物组合物
|
US20080186971A1
(en)
|
2007-02-02 |
2008-08-07 |
Tarari, Inc. |
Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
|
KR20090113382A
(ko)
|
2007-02-22 |
2009-10-30 |
아이알엠 엘엘씨 |
G 단백질-커플링된 수용체의 조절제로서의 티아졸 유도체
|
DE602008002733D1
(de)
|
2007-03-08 |
2010-11-04 |
Irm Llc |
Verbindungen und zusammensetzungen als modulatoren der gpr119-aktivität
|
EP1975612A1
(en)
|
2007-03-29 |
2008-10-01 |
Deutsches Institut für Ernährungsforschung Potsdam -Rehbrücke-Stiftung des öffentlichen Rechts- Vertreten durch den Stiftungsvorstand |
Agonists of bitter taste receptors and uses thereof
|
EP1975611A1
(en)
|
2007-03-29 |
2008-10-01 |
Deutsches Institut für Ernährungsforschung Potsdam -Rehbrücke-Stiftung des öffentlichen Rechts- Vertreten durch den Stiftungsvorstand |
Agonists of bitter taste receptors and uses thereof
|
US7572934B2
(en)
|
2007-04-16 |
2009-08-11 |
Amgen Inc. |
Substituted biphenyl GPR40 modulators
|
JP2010524941A
(ja)
|
2007-04-20 |
2010-07-22 |
シェーリング コーポレイション |
ピリミジノン誘導体およびそれらの使用方法
|
WO2008130581A1
(en)
|
2007-04-20 |
2008-10-30 |
Schering Corporation |
Pyrimidinone derivatives and methods of use thereof
|
CA2684618A1
(en)
|
2007-04-20 |
2008-10-30 |
Schering Corporation |
Tetrahydropyrido[4,3-d]pyrimidinone derivatives and methods of use thereof
|
JP5420400B2
(ja)
|
2007-04-26 |
2014-02-19 |
国立大学法人京都大学 |
Gタンパク質共役型レセプター作動剤
|
CN101668759A
(zh)
|
2007-05-04 |
2010-03-10 |
百时美施贵宝公司 |
[6,5]-双环gpr119g蛋白-偶合受体激动剂
|
ES2388967T3
(es)
|
2007-05-04 |
2012-10-22 |
Bristol-Myers Squibb Company |
Agonistas [6,6]- y [6,7]-bicíclicos del receptor GPR119 acoplado a la proteína G
|
WO2008144423A2
(en)
|
2007-05-15 |
2008-11-27 |
Medical College Of Georgia Research Institute, Inc. |
Compositions comprising a gpr109 ligand for treating disorders of the digestive tract and/or cancer
|
NZ582664A
(en)
|
2007-07-17 |
2012-03-30 |
Bristol Myers Squibb Co |
Pyridone gpr119 g protein-coupled receptor agonists
|
EP2185544B1
(en)
|
2007-07-19 |
2014-11-26 |
Cymabay Therapeutics, Inc. |
N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the rup3 or gpr119 for the treatment of diabetes and metabolic disorders
|
US20090042813A1
(en)
|
2007-08-10 |
2009-02-12 |
Sergey Michailovich Melnikov |
Hoodia extract oil compositions comprising medium chain triglycerides
|
WO2009033078A2
(en)
|
2007-09-05 |
2009-03-12 |
Raif Tawakol |
Compositions and methods for controlling cholesterol levels
|
JP2010539152A
(ja)
|
2007-09-10 |
2010-12-16 |
プロシディオン・リミテッド |
代謝障害の治療のための化合物
|
WO2009038204A1
(ja)
|
2007-09-17 |
2009-03-26 |
Pharma Frontier Co., Ltd. |
新規長鎖脂肪酸誘導体化合物及びそれら化合物を有効成分とするgタンパク質共役型レセプター作動剤
|
CA2697551C
(en)
|
2007-09-20 |
2013-03-12 |
Irm Llc |
Piperidine derivatives as modulators of gpr119 activity
|
BRPI0818253A2
(pt)
|
2007-10-10 |
2015-04-07 |
Amgen Inc |
Moduladores de gpr40 bifenil substituídos
|
GB0720390D0
(en)
|
2007-10-18 |
2007-11-28 |
Prosidion Ltd |
G-Protein coupled receptor agonists
|
GB0720389D0
(en)
|
2007-10-18 |
2008-11-12 |
Prosidion Ltd |
G-Protein Coupled Receptor Agonists
|
WO2009055331A2
(en)
|
2007-10-22 |
2009-04-30 |
Schering Corporation |
Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
|
JP2011016722A
(ja)
|
2007-10-23 |
2011-01-27 |
Astellas Pharma Inc |
チアゾリジンジオン化合物
|
TW200932219A
(en)
|
2007-10-24 |
2009-08-01 |
Astellas Pharma Inc |
Oxadiazolidinedione compound
|
US20100316736A1
(en)
|
2007-10-24 |
2010-12-16 |
Desert Labs Agriculture Cooperative Association Ltd. |
Appetite suppressant
|
WO2009058237A1
(en)
|
2007-10-29 |
2009-05-07 |
Merck & Co., Inc. |
Antidiabetic tricyclic compounds
|
JP5075211B2
(ja)
|
2008-01-29 |
2012-11-21 |
中森製薬株式会社 |
医薬組成物
|
EA201001330A1
(ru)
|
2008-02-22 |
2011-04-29 |
Айрм Ллк |
Соединения и композиции в качестве модуляторов активности gpr119
|
JP2011513233A
(ja)
|
2008-02-22 |
2011-04-28 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Gpr119活性モジュレーターとしての化合物および組成物
|
JP2011513232A
(ja)
|
2008-02-22 |
2011-04-28 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Gpr119活性のモジュレーターとしての化合物および組成物
|
WO2009106565A1
(en)
|
2008-02-27 |
2009-09-03 |
Biovitrum Ab (Publ) |
Agonists of gpr119
|
WO2009106561A1
(en)
|
2008-02-27 |
2009-09-03 |
Biovitrum Ab (Publ) |
Pyrazine compounds for treating gpr119 related disorders
|
WO2009117421A2
(en)
|
2008-03-17 |
2009-09-24 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
TW201002705A
(en)
|
2008-03-31 |
2010-01-16 |
Metabolex Inc |
Oxymethylene aryl compounds and uses thereof
|
BRPI0911118A2
(pt)
|
2008-04-07 |
2015-10-06 |
Irm Llc |
composto e compisições como moduladores de atividade de gpr119
|
EP2108960A1
(en)
|
2008-04-07 |
2009-10-14 |
Arena Pharmaceuticals, Inc. |
Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditons modulated by PYY
|
WO2009125804A1
(ja)
|
2008-04-09 |
2009-10-15 |
武田薬品工業株式会社 |
スクリーニング方法
|
AU2009249237A1
(en)
|
2008-05-19 |
2009-11-26 |
Schering Corporation |
Bicyclic heterocycle derivatives and use thereof as GPR119 modulators
|
US8188098B2
(en)
|
2008-05-19 |
2012-05-29 |
Hoffmann-La Roche Inc. |
GPR119 receptor agonists
|
WO2009140784A1
(en)
|
2008-05-23 |
2009-11-26 |
Givaudan Sa |
Bitter alkaloid containing consumables comprising bitter blockers
|
US20110071198A1
(en)
|
2008-05-27 |
2011-03-24 |
Lefkowitz Robert J |
Nicotinic acid receptor ligands
|
CN101695575A
(zh)
*
|
2008-05-29 |
2010-04-21 |
北京奥萨医药研究中心有限公司 |
含有他汀类降脂药物、双胍类降糖药物和烟酸的药物组合物
|
EP2298750A4
(en)
|
2008-06-02 |
2012-04-25 |
Msd Kk |
NOVEL ISOXAZOLE DERIVATIVE
|
WO2009150144A1
(en)
|
2008-06-10 |
2009-12-17 |
Inovacia Ab |
New gpr119modulators
|
US8546085B2
(en)
|
2008-06-13 |
2013-10-01 |
Givaudan Sa |
Methods of identifying modulators of the bitter taste receptor TAS2R44
|
AU2009271414A1
(en)
|
2008-06-20 |
2010-01-21 |
Metabolex, Inc. |
Aryl GPR119 agonists and uses thereof
|
GB0812031D0
(en)
|
2008-07-01 |
2008-08-06 |
7Tm Pharma As |
Thiazole derivatives
|
GB0812649D0
(en)
|
2008-07-10 |
2008-08-20 |
Prosidion Ltd |
Compounds
|
GB0812648D0
(en)
|
2008-07-10 |
2008-08-20 |
Prosidion Ltd |
Compounds
|
JP5309216B2
(ja)
|
2008-07-11 |
2013-10-09 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Gpr119活性のモジュレーターとしての4−フェノキシメチルピペリジン類
|
TW201006821A
(en)
|
2008-07-16 |
2010-02-16 |
Bristol Myers Squibb Co |
Pyridone and pyridazone analogues as GPR119 modulators
|
AU2009270971A1
(en)
|
2008-07-16 |
2010-01-21 |
Schering Corporation |
Bicyclic Heterocycle Derivatives and use thereof as GPR119 modulators
|
CN105152919A
(zh)
|
2008-07-28 |
2015-12-16 |
赛丹思科大学 |
用于治疗代谢疾病的化合物
|
WO2010013849A1
(ja)
|
2008-08-01 |
2010-02-04 |
日本ケミファ株式会社 |
Gpr119作動薬
|
JP5539881B2
(ja)
|
2008-08-29 |
2014-07-02 |
サントリーホールディングス株式会社 |
新規エピガロカテキンガレート4量体、およびそれらを含む血管内皮機能改善剤
|
EP2329271B1
(en)
|
2008-08-29 |
2012-06-20 |
Givaudan SA |
Methods to identify modulators
|
JP2012502081A
(ja)
|
2008-09-10 |
2012-01-26 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
糖尿病及び関連症状の治療のための組み合わせ治療
|
WO2010030360A1
(en)
|
2008-09-11 |
2010-03-18 |
Arena Pharmaceuticals, Inc. |
3H-IMIDAZO[4,5-b]PYRIDIN-5-OL DERIVATIVES USEFUL IN THE TREATMENT OF GPR81 RECEPTOR DISORDERS
|
CA2739888C
(en)
|
2008-10-15 |
2013-11-19 |
Amgen Inc. |
Spirocyclic gpr40 modulators
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
CA2740366A1
(en)
|
2008-10-21 |
2010-04-29 |
Metabolex, Inc. |
Aryl gpr120 receptor agonists and uses thereof
|
WO2010060198A1
(en)
|
2008-11-26 |
2010-06-03 |
West Central Envirotech Inc. |
Composition and method for controlling insects
|
AR074760A1
(es)
|
2008-12-18 |
2011-02-09 |
Metabolex Inc |
Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
|
WO2010074271A1
(ja)
|
2008-12-26 |
2010-07-01 |
武田薬品工業株式会社 |
糖尿病治療剤
|
WO2010076879A1
(ja)
|
2009-01-03 |
2010-07-08 |
静岡県公立大学法人 |
硫酸化c-配糖体及びその単離方法並びに合成方法
|
JPWO2010084944A1
(ja)
|
2009-01-22 |
2012-07-19 |
田辺三菱製薬株式会社 |
新規ピロロ[2,3−d]ピリミジン化合物
|
WO2010085522A1
(en)
|
2009-01-23 |
2010-07-29 |
Schering Corporation |
Pentafluorosulpholane-containing antidiabetic compounds
|
CA2749891A1
(en)
|
2009-01-23 |
2010-07-29 |
Hubert B. Josien |
Bridged and fused antidiabetic compounds
|
EP2389226B1
(en)
|
2009-01-23 |
2013-11-20 |
Merck Sharp & Dohme Corp. |
Bridged and fused heterocyclic antidiabetic compounds
|
WO2010088518A2
(en)
|
2009-01-31 |
2010-08-05 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
WO2010091176A1
(en)
|
2009-02-05 |
2010-08-12 |
Schering Corporation |
Phthalazine-containing antidiabetic compounds
|
WO2010095663A1
(ja)
|
2009-02-18 |
2010-08-26 |
武田薬品工業株式会社 |
縮合複素環化合物
|
GB0904287D0
(en)
|
2009-03-12 |
2009-04-22 |
Prosidion Ltd |
Compounds for the treatment of metabolic disorders
|
GB0904285D0
(en)
|
2009-03-12 |
2009-04-22 |
Prosidion Ltd |
Compounds for the treatment of metabolic disorders
|
GB0904284D0
(en)
|
2009-03-12 |
2009-04-22 |
Prosidion Ltd |
Compounds for the treatment of metabolic disorders
|
EP2408780A2
(en)
|
2009-03-20 |
2012-01-25 |
Pfizer Inc. |
3-oxa-7-azabicycloý3.3.1¨nonanes
|
JPWO2010123016A1
(ja)
|
2009-04-22 |
2012-10-25 |
アステラス製薬株式会社 |
カルボン酸化合物
|
JP2012136438A
(ja)
|
2009-04-22 |
2012-07-19 |
Astellas Pharma Inc |
テトラゾール化合物
|
JP2012136439A
(ja)
|
2009-04-24 |
2012-07-19 |
Nippon Chemiphar Co Ltd |
ジアザスピロアルカン誘導体
|
CA2759843A1
(en)
|
2009-05-08 |
2010-11-10 |
Pfizer Inc. |
Gpr 119 modulators
|
EP2427448A1
(en)
|
2009-05-08 |
2012-03-14 |
Pfizer Inc. |
Gpr 119 modulators
|
NZ596467A
(en)
|
2009-06-05 |
2014-01-31 |
Pfizer |
L- ( piperidin-4-yl) -pyrazole derivatives as gpr 119 modulators
|
WO2010143733A1
(en)
|
2009-06-09 |
2010-12-16 |
Takeda Pharmaceutical Company Limited |
Novel fused cyclic compound and use thereof
|
AR077642A1
(es)
|
2009-07-09 |
2011-09-14 |
Arena Pharm Inc |
Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
|
AR077638A1
(es)
|
2009-07-15 |
2011-09-14 |
Lilly Co Eli |
Compuesto de (metanosulfonil -piperidin )-( alcoxi-aril) -tetrahidro- piridina , composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento de diabetes u obesidad
|
US8709745B2
(en)
|
2009-07-28 |
2014-04-29 |
Deutsches Institut Für Ernährungsforschung Potsdam-Rehbrücke |
Methods for isolating ligands of the human bitter taste receptor TAS2R49
|
WO2011014520A2
(en)
|
2009-07-29 |
2011-02-03 |
Irm Llc |
Compounds and compositions as modulators of gpr119 activity
|
JPWO2011025006A1
(ja)
|
2009-08-31 |
2013-01-31 |
日本ケミファ株式会社 |
Gpr119作動薬
|
CN102724877B
(zh)
|
2009-09-01 |
2015-05-13 |
凯特贝希制药公司 |
脂肪酸烟酸缀合物及其用途
|
WO2011030139A1
(en)
|
2009-09-11 |
2011-03-17 |
Astrazeneca Ab |
4- (pyrimidin-2-yl) -piperazine and 4- (pyrimidin-2-yl) -piperidine derivatives as gpr119 modulators
|
CA2772188A1
(en)
|
2009-09-23 |
2011-03-31 |
Pfizer Inc. |
Gpr 119 modulators
|
US20110082156A1
(en)
|
2009-10-05 |
2011-04-07 |
Milne Jill C |
Fatty acid acipimox derivatives and their uses
|
US20110082202A1
(en)
|
2009-10-05 |
2011-04-07 |
Milne Jill C |
Fatty acid acifran derivatives and their uses
|
AU2010303670A1
(en)
|
2009-10-06 |
2012-03-29 |
Bristol-Myers Squibb Company |
Pyrrolidine GPR40 modulators
|
MX2012004078A
(es)
|
2009-10-09 |
2012-07-25 |
Irm Llc |
Compuestos y composiciones como moduladores de la actividad de gpr119.
|
WO2011051966A2
(en)
*
|
2009-10-12 |
2011-05-05 |
Ipca Laboratories Limited |
Pharmaceutical compositions for the treatment/prophylaxis of non-alcoholic fatty liver disease
|
WO2011050163A1
(en)
|
2009-10-21 |
2011-04-28 |
Wisconsin Alumni Research Foundation |
Method of preventing type 1 diabetes
|
EP2493307B1
(en)
|
2009-10-29 |
2016-04-27 |
Merck Sharp & Dohme Corp. |
Bridged bicyclic piperidine derivatives and methods of use thereof
|
JPWO2011052756A1
(ja)
|
2009-10-30 |
2013-03-21 |
持田製薬株式会社 |
新規3−ヒドロキシ−5−アリールイソキサゾール誘導体
|
WO2011057110A1
(en)
|
2009-11-06 |
2011-05-12 |
Ruprecht-Karls-Universitat-Heidelberg |
Gpr109a agonists for the treatment of cerebral ischemia
|
JPWO2011055770A1
(ja)
|
2009-11-06 |
2013-03-28 |
武田薬品工業株式会社 |
縮合複素環化合物
|
EP2504342A1
(en)
|
2009-11-23 |
2012-10-03 |
Pfizer Inc. |
Imidazo-pyrazoles as gpr119 inhibitors
|
US9301929B2
(en)
|
2009-11-24 |
2016-04-05 |
Merck Sharp & Dohme Corp. |
Substituted biaryl derivatives and methods of use thereof
|
CN102762259A
(zh)
|
2009-12-04 |
2012-10-31 |
高露洁-棕榄公司 |
含有倒捻子提取物的口腔组合物及相关方法
|
EP2332427A1
(en)
|
2009-12-07 |
2011-06-15 |
Nestec S.A. |
low caloric fat replacers
|
WO2011072132A1
(en)
|
2009-12-09 |
2011-06-16 |
The Regents Of The University Of California |
Methods of treating inflammatory conditions
|
CN102812003B
(zh)
|
2009-12-18 |
2015-01-21 |
欧洲筛选有限公司 |
吡咯烷羧酸衍生物、药物组合物以及在代谢紊乱中作为g-蛋白偶联受体43(gpr43)激动剂使用的方法
|
JP2013047188A
(ja)
|
2009-12-24 |
2013-03-07 |
Nippon Chemiphar Co Ltd |
Gpr119作動薬
|
CA2785674A1
(en)
|
2009-12-25 |
2011-06-30 |
Mochida Pharmaceutical Co., Ltd. |
Novel 3-hydroxy-5-arylisothiazole derivative
|
EP2345646A1
(en)
|
2010-01-14 |
2011-07-20 |
InterMed Discovery GmbH |
Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions
|
WO2011092284A1
(en)
|
2010-01-29 |
2011-08-04 |
Euroscreen S.A. |
Novel amino acid derivatives and their use as gpr43 receptor modulators
|
KR20120130104A
(ko)
|
2010-02-01 |
2012-11-28 |
닛뽕 케미파 가부시키가이샤 |
Gpr119 작동약
|
CN101785763B
(zh)
*
|
2010-02-04 |
2011-11-23 |
贵州天安药业股份有限公司 |
一种盐酸二甲双胍肠溶缓释片及其制备方法
|
WO2011113947A1
(en)
|
2010-03-18 |
2011-09-22 |
Boehringer Ingelheim International Gmbh |
Combination of a gpr119 agonist and the dpp-iv inhibitor linagliptin for use in the treatment of diabetes and related conditions
|
MX2012011631A
(es)
|
2010-04-06 |
2013-01-18 |
Arena Pharm Inc |
Moduladores del receptor gpr119 y el tratamiento de trastornos relacionados con el mismo.
|
MX2012011460A
(es)
|
2010-04-08 |
2012-11-23 |
Squibb Bristol Myers Co |
Analogos de pirimidinilpiperidiniloxipiridinona como moduladores de gpr119.
|
GB201006167D0
(en)
|
2010-04-14 |
2010-05-26 |
Prosidion Ltd |
Compounds for the treatment of metabolic disorders
|
GB201006166D0
(en)
|
2010-04-14 |
2010-05-26 |
Prosidion Ltd |
Compounds for the treatment of metabolic disorders
|
US8940716B2
(en)
|
2010-05-06 |
2015-01-27 |
Bristol-Myers Squibb Company |
Bicyclic heteroaryl compounds as GPR119 modulators
|
US8729084B2
(en)
|
2010-05-06 |
2014-05-20 |
Bristol-Myers Squibb Company |
Benzofuranyl analogues as GPR119 modulators
|
EP2566864B1
(en)
|
2010-05-07 |
2014-09-03 |
Boehringer Ingelheim International GmbH |
Pyridazinones as gpr119 agonists
|
JP2013530947A
(ja)
|
2010-05-17 |
2013-08-01 |
アレイ バイオファーマ、インコーポレイテッド |
Gpr119調節薬としてのピペリジニル置換ラクタム
|
WO2011145718A1
(ja)
|
2010-05-21 |
2011-11-24 |
田辺三菱製薬株式会社 |
新規ピロロ[2,3-d]ピリミジン化合物
|
TW201202230A
(en)
|
2010-05-24 |
2012-01-16 |
Mitsubishi Tanabe Pharma Corp |
Novel quinazoline compound
|
TW201209054A
(en)
|
2010-05-28 |
2012-03-01 |
Prosidion Ltd |
Novel compounds
|
US20110293753A1
(en)
|
2010-05-28 |
2011-12-01 |
Louis Bellafiore |
Tocotrienol Compositions
|
WO2011151436A2
(en)
|
2010-06-04 |
2011-12-08 |
Euroscreen S.A. |
Novel compounds, method for use them and pharmaceutical composition containing them
|
GB201009873D0
(en)
|
2010-06-14 |
2010-07-21 |
Univ Leuven Kath |
Method for hydrogenation of isoalpha-acids (isohumulones) to hexahydro-iso-alpha-acids (hexahydro-isohumulones) by using heterogeneous ruthenium
|
ES2526124T3
(es)
|
2010-06-16 |
2015-01-07 |
Cymabay Therapeutics, Inc. |
Agonistas del receptor GPR120 y sus usos
|
US20130096141A1
(en)
|
2010-06-18 |
2013-04-18 |
Bernard R. Neustadt |
Bicyclic heterocycle derivatives and methods of use thereof
|
EP2397039A1
(en)
|
2010-06-21 |
2011-12-21 |
Abbott Laboratories |
Compositions for delaying progression of diabetes using Salacia oblonga extract
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
TW201215388A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Sa |
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
|
TW201221505A
(en)
|
2010-07-05 |
2012-06-01 |
Sanofi Sa |
Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
|
WO2012006955A1
(en)
|
2010-07-14 |
2012-01-19 |
Zhejiang Beta Pharma Inc. |
Compounds for treatment of metabolic disorders
|
KR20120011357A
(ko)
|
2010-07-23 |
2012-02-08 |
현대약품 주식회사 |
치환된 피리디논 유도체 및 이의 제조방법
|
RU2627703C2
(ru)
|
2010-07-23 |
2017-08-10 |
Конекшис Лайф Сайенсиз Пвт. Лтд. |
Агонисты gpr40
|
WO2012025811A1
(en)
|
2010-08-23 |
2012-03-01 |
Lupin Limited |
Indolylpyrimidines as modulators of gpr119
|
AU2011301934A1
(en)
|
2010-09-17 |
2013-05-16 |
Array Biopharma Inc. |
Piperidinyl-substituted lactams as GPR 119 modulators
|
US10894787B2
(en)
|
2010-09-22 |
2021-01-19 |
Arena Pharmaceuticals, Inc. |
Modulators of the GPR119 receptor and the treatment of disorders related thereto
|
CN102432598A
(zh)
|
2010-09-29 |
2012-05-02 |
江苏恒瑞医药股份有限公司 |
三环化合物、其制备方法及其在医药上的应用
|
JP2014001144A
(ja)
|
2010-10-08 |
2014-01-09 |
Nippon Chemiphar Co Ltd |
Gpr119作動薬
|
US9040525B2
(en)
|
2010-10-08 |
2015-05-26 |
Mochida Pharmaceutical Co., Ltd. |
Cyclic amide derivative
|
NZ608708A
(en)
|
2010-10-08 |
2015-05-29 |
Cadila Healthcare Ltd |
Novel gpr 119 agonists
|
CN101978956B
(zh)
*
|
2010-10-13 |
2012-03-28 |
北京京丰制药有限公司 |
盐酸二甲双胍肠溶片及其制备方法
|
US8410178B2
(en)
|
2010-10-30 |
2013-04-02 |
Kindex Therapeutics, Llc |
CIS 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-derivatives, substantially enantiomerically pure compositions and methods
|
JP2013543885A
(ja)
|
2010-11-23 |
2013-12-09 |
ファイザー・インク |
Gpr119調節薬としての4−(5−シアノ−ピラゾール−1−イル)−ピペリジン誘導体
|
CA2818050A1
(en)
|
2010-11-26 |
2012-05-31 |
Lupin Limited |
Bicyclic gpr119 modulators
|
US20120302566A1
(en)
|
2010-12-01 |
2012-11-29 |
Boehringer Ingelheim International Gmbh |
Indanyloxydihydrobenzofuranylacetic acids
|
WO2012077655A1
(ja)
|
2010-12-07 |
2012-06-14 |
塩野義製薬株式会社 |
Gpr119アゴニスト活性を有するスピロ誘導体
|
UY33805A
(es)
|
2010-12-17 |
2012-07-31 |
Boehringer Ingelheim Int |
?Derivados de dihidrobenzofuranil-piperidinilo, aza-dihidrobenzofuranilpiperidinilo y diaza-dihidrobenzofuranil-piperidinilo, composiciones farmacéuticas que los contienen y usos de los mismos?.
|
EP2661438A4
(en)
|
2011-01-03 |
2014-06-11 |
Hanmi Pharm Ind Co Ltd |
NEW BICYCLIC COMPOUND FOR THE MODULATION OF G PROTEIN-COUPLED RECEPTORS
|
AR084905A1
(es)
|
2011-01-21 |
2013-07-10 |
Boehringer Ingelheim Int |
Derivados de 2,3-dihidro-furo[2,3-c]piridina, composiciones farmaceuticas que los comprenden y su uso en el tratamiento de enfermedades mediadas por la activacion del receptor gpr119 acoplado a proteinas g
|
CN102617548A
(zh)
|
2011-01-31 |
2012-08-01 |
北京赛林泰医药技术有限公司 |
作为gpr受体激动剂的双环杂芳基化合物及其组合物和应用
|
TW201309639A
(zh)
|
2011-02-17 |
2013-03-01 |
Lg Life Sciences Ltd |
作為gpr119促效劑之肟衍生物
|
EP2686312B1
(en)
|
2011-03-14 |
2016-08-31 |
Boehringer Ingelheim International GmbH |
N-cyclopropyl-n-piperidinylbenzamides as gpr119 modulators
|
US20140018371A1
(en)
|
2011-04-01 |
2014-01-16 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
EP2694465A4
(en)
|
2011-04-08 |
2015-03-18 |
Univ Syddansk |
SUBSTITUTED ORTHOFLUOR COMPOUNDS FOR THE TREATMENT OF METABOLISM DISEASES
|
US20140066369A1
(en)
|
2011-04-19 |
2014-03-06 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
US20140038889A1
(en)
|
2011-04-22 |
2014-02-06 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
WO2012145604A1
(en)
|
2011-04-22 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
JP5420796B2
(ja)
|
2011-04-27 |
2014-02-19 |
持田製薬株式会社 |
新規3−ヒドロキシイソチアゾール1−オキシド誘導体
|
AU2012248627A1
(en)
|
2011-04-28 |
2013-11-14 |
Mochida Pharmaceutical Co., Ltd. |
Cyclic amide derivative
|
KR101401496B1
(ko)
|
2011-05-12 |
2014-06-11 |
한국화학연구원 |
티에노피리미딘 유도체, 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 당뇨 관련 질환의 예방 또는 치료용 약학적 조성물
|
WO2012170702A1
(en)
|
2011-06-08 |
2012-12-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
WO2012168315A1
(en)
|
2011-06-09 |
2012-12-13 |
Boehringer Ingelheim International Gmbh |
Substituted piperidines as gpr119 modulators for the treatment of metabolic disorders
|
JP2014159376A
(ja)
|
2011-06-17 |
2014-09-04 |
Taisho Pharmaceutical Co Ltd |
アザスピロアルカン化合物
|
EP2731944A1
(en)
|
2011-07-15 |
2014-05-21 |
Pfizer Inc |
Gpr 119 modulators
|
WO2013055910A1
(en)
|
2011-10-12 |
2013-04-18 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
CN102357088A
(zh)
*
|
2011-10-26 |
2012-02-22 |
河北山姆士药业有限公司 |
盐酸二甲双胍肠溶片
|